SCHEMBL3569499

SCHEMBL3569499

CN1CCN(c2ccc(NC=C3C(=O)NC(=O)c4ccc(N)cc43)cc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
ADRA2C P18825 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
GFER P55789 1/20 0.44
PTK2B Q14289 1/20 0.44
ESR2 Q92731 1/20 0.44
CSF1R P07333 1/20 0.42
FLT3 P36888 4/20 0.41
EGFR P00533 1/20 0.39
DYRK3 O43781 3/20 0.38
DYRK1A Q13627 3/20 0.38
DYRK2 Q92630 3/20 0.38
DYRK1B Q9Y463 3/20 0.38
CLK1 P49759 2/20 0.38
CLK2 P49760 2/20 0.38
CLK3 P49761 2/20 0.38
GSK3B P49841 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3569494 1.00 ALDH1A1 (0.44) ALDH1A1MAPTADRA2CKMT2AKDM4E
SCHEMBL13369079 0.92 KDM4E (0.43) ALDH1A1MAPTADRA2CKMT2AKDM4E
SCHEMBL3568462 0.90 MAPT (0.43) ALDH1A1MAPTADRA2CKMT2AKDM4E
SCHEMBL3568464 0.90 MAPT (0.43) ALDH1A1MAPTADRA2CKMT2AKDM4E
SCHEMBL3563875 0.89 MAPKAPK2 (0.47) ALDH1A1MAPTADRA2CKMT2AKDM4E
SCHEMBL3563877 0.89 MAPKAPK2 (0.47) ALDH1A1MAPTADRA2CKMT2AKDM4E
SCHEMBL13343924 0.88 ALDH1A1 (0.43) ALDH1A1MAPTKMT2AGFERCSF1R
SCHEMBL3562396 0.87 PDGFRB (0.44) ALDH1A1MAPTKMT2AGAACSF1R
SCHEMBL3656639 0.87 CSF1R (0.42) ALDH1A1MAPTKMT2ACSF1RDYRK3
SCHEMBL3656634 0.87 CSF1R (0.42) ALDH1A1MAPTKMT2ACSF1RDYRK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7713994-B2 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof WYETH LLC (US) 2010-05-11 US disclosed
EP-1963273-A2 SUBSTITUTED ISOQUINOLINE-1,3(2H,4H)-DIONES, 1-THIOXO-1,4-DIHYDRO-2H-ISOQUINOLINE-3-ONES AND 1,4-DIHYDRO-3(2H)-ISOQUINOLONES AND USE THEREOF AS KINASE INHIBITORS Wyeth a Corporation of the State of Delaware (US) 2008-09-03 EP disclosed
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US disclosed
WO-2007075783-A2 SUBSTITUTED ISOQUINOLINE-1,3(2H,4H)-DIONES, 1-THIOXO-1,4-DIHYDRO-2H-ISOQUINOLINE-3-ONES AND 1,4-DIHYDRO-3(2H)-ISOQUINOLONES AND USE THEREOF AS KINASE INHIBITOR WYETH (US) 2007-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof SULT1E1, RECQL, HAX1 ALDH1A1 61/4885MAPT 4095/4885ADRA2C 536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.